MBE
Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics
Peter S. Kim Joseph J. Crivelli Il-Kyu Choi Chae-Ok Yun Joanna R. Wares
The past century's description of oncolytic virotherapy as a cancer treatment involving specially-engineered viruses that exploit immune deficiencies to selectively lyse cancer cells is no longer adequate. Some of the most promising therapeutic candidates are now being engineered to produce immunostimulatory factors, such as cytokines and co-stimulatory molecules, which, in addition to viral oncolysis, initiate a cytotoxic immune attack against the tumor.
    This study addresses the combined effects of viral oncolysis and T-cell-mediated oncolysis. We employ a mathematical model of virotherapy that induces release of cytokine IL-12 and co-stimulatory molecule 4-1BB ligand. We found that the model closely matches previously published data, and while viral oncolysis is fundamental in reducing tumor burden, increased stimulation of cytotoxic T cells leads to a short-term reduction in tumor size, but a faster relapse.
    In addition, we found that combinations of specialist viruses that express either IL-12 or 4-1BBL might initially act more potently against tumors than a generalist virus that simultaneously expresses both, but the advantage is likely not large enough to replace treatment using the generalist virus. Finally, according to our model and its current assumptions, virotherapy appears to be optimizable through targeted design and treatment combinations to substantially improve therapeutic outcomes.
keywords: co-stimulatory molecules adenovirus ordinary differential equations model. mathematical model cytokines Oncolytic virotherapy
MBE
Application of ecological and mathematical theory to cancer: New challenges
Yangjin Kim Avner Friedman Eugene Kashdan Urszula Ledzewicz Chae-Ok Yun
According to the World Health Organization, cancer is among the leading causes of morbidity and mortality worldwide. Despite enormous efforts of cancer researchers all around the world, the mechanisms underlying its origin, formation, progression, therapeutic cure or control are still not fully understood. Cancer is a complex, multi-scale process, in which genetic mutations occurring at a sub-cellular level manifest themselves as functional changes at the cellular and tissue scale.

For more information please click the “Full Text” above.
keywords:
MBE
Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections
Joanna R. Wares Joseph J. Crivelli Chae-Ok Yun Il-Kyu Choi Jana L. Gevertz Peter S. Kim
Oncolytic viruses (OVs) are used to treat cancer, as they selectively replicate inside of and lyse tumor cells. The efficacy of this process is limited and new OVs are being designed to mediate tumor cell release of cytokines and co-stimulatory molecules, which attract cytotoxic T cells to target tumor cells, thus increasing the tumor-killing effects of OVs. To further promote treatment efficacy, OVs can be combined with other treatments, such as was done by Huang et al., who showed that combining OV injections with dendritic cell (DC) injections was a more effective treatment than either treatment alone. To further investigate this combination, we built a mathematical model consisting of a system of ordinary differential equations and fit the model to the hierarchical data provided from Huang et al. We used the model to determine the effect of varying doses of OV and DC injections and to test alternative treatment strategies. We found that the DC dose given in Huang et al. was near a bifurcation point and that a slightly larger dose could cause complete eradication of the tumor. Further, the model results suggest that it is more effective to treat a tumor with immunostimulatory oncolytic viruses first and then follow-up with a sequence of DCs than to alternate OV and DC injections. This protocol, which was not considered in the experiments of Huang et al., allows the infection to initially thrive before the immune response is enhanced. Taken together, our work shows how the ordering, temporal spacing, and dosage of OV and DC can be chosen to maximize efficacy and to potentially eliminate tumors altogether.
keywords: ordinary differential equations model. co-stimulatory molecules Oncolytic virotherapy cytokines mathematical model adenovirus

Year of publication

Related Authors

Related Keywords

[Back to Top]